Connective Capital Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,013 shares of the exchange traded fund’s stock, valued at approximately $977,000. SPDR S&P Biotech ETF makes up about 0.6% of Connective Capital Management LLC’s investment portfolio, making the stock its 19th biggest position.
Several other hedge funds have also recently made changes to their positions in the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter valued at $27,000. Intesa Sanpaolo Wealth Management purchased a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $30,000. Legacy Wealth Managment LLC ID purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at $32,000. Smartleaf Asset Management LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter worth $32,000. Finally, Acumen Wealth Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $34,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA:XBI opened at $140.72 on Friday. The firm has a market cap of $8.98 billion, a PE ratio of 11.47 and a beta of 0.85. The firm’s 50 day simple moving average is $133.36 and its 200-day simple moving average is $127.61. SPDR S&P Biotech ETF has a one year low of $80.90 and a one year high of $143.46.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
